NYLI Candriam U.S. Mid Cap Equity ETFIQSM

The NYSE Arca listing of the NYLI Candriam U.S. Mid Cap Equity ETF (ticker: IQSM) arrived with the quiet of a pension fund manager nodding at a quarterly report. The mandate-"U.S. Mid Cap Equity"-sounds like a committee wrote it after three cups of tea, but the reality is simpler: this wrapper owns a basket of mid-sized U.S. companies, and in exchange, the issuer pockets an annual fee of 0.40% for the privilege of calling it a theme. The glossy pitch is thin; the filing trail is thick. (source: SEC EDGAR fund search for IQSM, https://www.sec.gov/edgar/search/#/q=IQSM)

The fund’s presence on Nasdaq is as understated as a filing trail stack in a back office. The exchange’s page lists IQSM with the same economy of language it reserves for forgotten ETFs and dusty closed-end funds. There are no flashing lights, no analyst quotes, no evidence that the ticker is anything more than a listed wrapper around a mid-cap basket that could shuffle off quietly into the night. The issuer’s marketing material is nowhere to be found in the evidence, so treat any thematic claims as issuer assertions rather than sourced facts. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/iqsm)

What IQSM actually holds is not disclosed in the supplied evidence. The SEC EDGAR search turns up the fund’s registration documents-dry, precise, and devoid of holdings snapshots or expense-ratio deep dives. The FINRA Fund Analyzer can confirm the 0.40% fee, but it cannot tell you whether the basket skews toward value, growth, or a bit of both. The fund’s fact sheet and holdings are absent from the evidence, so any claim about concentration, sector mix, or geographic tilt is speculation dressed as analysis. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)

For now, IQSM is a listed wrapper with a mandate, a fee, and a Nasdaq page that reads like a library entry. The chart route is live on Nasdaq’s platform, but the evidence does not supply levels, volumes, or any trading context beyond the ticker’s existence. Treat the chart as a price-time series, not a map to a trade. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/iqsm)

What changed today? Nothing that the evidence shows. The fund’s price, holdings, flows, and trading volumes are not parsed in the supplied materials. The only concrete facts are the ticker’s listing, the mandate’s wording, and the 0.40% fee, all sourced directly from SEC and Nasdaq pages. If you are looking for a reason to buy, sell, or hold, the evidence is silent. (source: SEC EDGAR fund search for IQSM, https://www.sec.gov/edgar/search/#/q=IQSM; Nasdaq, https://www.nasdaq.com/market-activity/etf/iqsm)

The thinness of the evidence is a finding, not a flaw. It simply means that IQSM is a listed wrapper whose inner workings-holdings, concentration, tracking error, performance versus benchmark-are not disclosed in the materials supplied here. If you want to know what the fund holds, you will need the issuer’s fact sheet or holdings file, neither of which appears in the evidence. Until then, the fund remains a ticker, a mandate, and a fee. (source: SEC EDGAR fund search for IQSM, https://www.sec.gov/edgar/search/#/q=IQSM)